poisar

Stocks · News reference

Silo Pharma Reports Third Quarter 2026 Financial Results

Fiscal.ai

Silo Pharma reported its financial results for the third quarter of 2026, showing zero revenue and a continued operating loss.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Silo Pharma, Inc. (SILO)

    Filed: 2026-11-06 AccNo: 0001213900-26-116982 Size: 738 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits